Fig. 3From: Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanismMSI-1436 inhibits foam cell formation and increases cholesterol efflux. MSI-1436 treatment decreases foam cell formation (A, B) and improves specific cholesterol efflux (C, D) in an AMPK- and dose dependent manner. Data are represented as mean ± S.E.M. and were analysed by bootstrapped ANOVA followed by Bonferonni-corrected multiple bootstrapped t tests in case of a significant omnibus testBack to article page